ID

35010

Descripción

Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02338115

Link

https://clinicaltrials.gov/show/NCT02338115

Palabras clave

Versiones (1)
  1. 8/2/19 8/2/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

8 de febrero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT02338115

Inglés

Eligibility Breast Cancer NCT02338115

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of invasive breast cancer
Descripción

Invasive carcinoma of breast

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0853879
systemic treatment with paclitaxel for curative intent (neoadjuvant, adjuvant, or oligometastatic disease per pi discretion)
Descripción

Paclitaxel | Systemic therapy Curative | Neoadjuvant Therapy Disease | Adjuvant therapy Disease | Neoplasm Metastasis Few

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0144576
UMLS CUI [2,1]
C1515119
UMLS CUI [2,2]
C1276305
UMLS CUI [3,1]
C0600558
UMLS CUI [3,2]
C0012634
UMLS CUI [4,1]
C0677850
UMLS CUI [4,2]
C0012634
UMLS CUI [5,1]
C0027627
UMLS CUI [5,2]
C0205388
80 mg/m2 1-hour infusions weekly for up to 12 weeks
Descripción

Infusions U/week

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0574032
UMLS CUI [1,2]
C0560588
female sex
Descripción

Gender

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
>18 years old
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
ability to understand and the willingness to sign a written informed consent.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
any prior or concurrent treatment with neurotoxic chemotherapy including any taxane, vinca alkaloid, platinum, bortezomib, or thalidomide. note that concurrent biologic treatment with trastuzumab/pertuzumab for her2+ patients or prior treatment with adriamycin/cyclophosphamide are not reasons for exclusion.
Descripción

Chemotherapy Neurotoxic agents | taxane | Vinca Alkaloids | Platinum | bortezomib | Thalidomide

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0260049
UMLS CUI [2]
C0215136
UMLS CUI [3]
C0042672
UMLS CUI [4]
C0032207
UMLS CUI [5]
C1176309
UMLS CUI [6]
C0039736
distant metastatic disease
Descripción

Distant metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1269798
concurrent treatment with duloxetine or enrollment on clinical study of neuroprotective agent
Descripción

duloxetine | Study Subject Participation Status | Neuroprotective Agents

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0245561
UMLS CUI [2]
C2348568
UMLS CUI [3]
C0242912
history of allergic reaction to paclitaxel or cremophor el
Descripción

Paclitaxel allergy | Hypersensitivity Cremophor EL

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0570707
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0056476
current signs or symptoms of severe peripheral neuropathy
Descripción

Sign or Symptom Peripheral Neuropathy Severe

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3540840
UMLS CUI [1,2]
C0031117
UMLS CUI [1,3]
C0205082
known family history of hereditary peripheral neuropathy or charcot-marie-tooth disease
Descripción

Family history Hereditary peripheral neuropathy | Family history of Charcot-Marie-Tooth disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0241889
UMLS CUI [1,2]
C0392553
UMLS CUI [2]
C2316866
known current pregnancy
Descripción

Pregnancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT02338115

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Invasive carcinoma of breast
Item
diagnosis of invasive breast cancer
boolean
C0853879 (UMLS CUI [1])
Paclitaxel | Systemic therapy Curative | Neoadjuvant Therapy Disease | Adjuvant therapy Disease | Neoplasm Metastasis Few
Item
systemic treatment with paclitaxel for curative intent (neoadjuvant, adjuvant, or oligometastatic disease per pi discretion)
boolean
C0144576 (UMLS CUI [1])
C1515119 (UMLS CUI [2,1])
C1276305 (UMLS CUI [2,2])
C0600558 (UMLS CUI [3,1])
C0012634 (UMLS CUI [3,2])
C0677850 (UMLS CUI [4,1])
C0012634 (UMLS CUI [4,2])
C0027627 (UMLS CUI [5,1])
C0205388 (UMLS CUI [5,2])
Infusions U/week
Item
80 mg/m2 1-hour infusions weekly for up to 12 weeks
boolean
C0574032 (UMLS CUI [1,1])
C0560588 (UMLS CUI [1,2])
Gender
Item
female sex
boolean
C0079399 (UMLS CUI [1])
Age
Item
>18 years old
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
ability to understand and the willingness to sign a written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Chemotherapy Neurotoxic agents | taxane | Vinca Alkaloids | Platinum | bortezomib | Thalidomide
Item
any prior or concurrent treatment with neurotoxic chemotherapy including any taxane, vinca alkaloid, platinum, bortezomib, or thalidomide. note that concurrent biologic treatment with trastuzumab/pertuzumab for her2+ patients or prior treatment with adriamycin/cyclophosphamide are not reasons for exclusion.
boolean
C0392920 (UMLS CUI [1,1])
C0260049 (UMLS CUI [1,2])
C0215136 (UMLS CUI [2])
C0042672 (UMLS CUI [3])
C0032207 (UMLS CUI [4])
C1176309 (UMLS CUI [5])
C0039736 (UMLS CUI [6])
Distant metastasis
Item
distant metastatic disease
boolean
C1269798 (UMLS CUI [1])
duloxetine | Study Subject Participation Status | Neuroprotective Agents
Item
concurrent treatment with duloxetine or enrollment on clinical study of neuroprotective agent
boolean
C0245561 (UMLS CUI [1])
C2348568 (UMLS CUI [2])
C0242912 (UMLS CUI [3])
Paclitaxel allergy | Hypersensitivity Cremophor EL
Item
history of allergic reaction to paclitaxel or cremophor el
boolean
C0570707 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0056476 (UMLS CUI [2,2])
Sign or Symptom Peripheral Neuropathy Severe
Item
current signs or symptoms of severe peripheral neuropathy
boolean
C3540840 (UMLS CUI [1,1])
C0031117 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
Family history Hereditary peripheral neuropathy | Family history of Charcot-Marie-Tooth disease
Item
known family history of hereditary peripheral neuropathy or charcot-marie-tooth disease
boolean
C0241889 (UMLS CUI [1,1])
C0392553 (UMLS CUI [1,2])
C2316866 (UMLS CUI [2])
Pregnancy
Item
known current pregnancy
boolean
C0032961 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial